INS and metabolic disease: Disruption of mitochondrial homeostasis results in adverse effects on lipid metabolism, adipocyte differentiation, oxidative capacity, inflammation, insulin sensitivity, and thermogenesis, culminating in metabolic diseases [8,15,17,18].